参考文献:1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18鈥?9. CrossRef 2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990鈥?020: global burden of disease study. Lancet. 1997;349:1498鈥?04. CrossRef 3. Gaspar MJ, Arribas I, Coca MC, Diez-Alonso M. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol. 2001;22:318鈥?2. CrossRef 4. Marrelli D, et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57:55鈥?2. CrossRef 5. Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002;22:2311鈥?. 6. Takahashi Y, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142鈥?. CrossRef 7. Hatfield S, Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res. 2008;331:57鈥?6. CrossRef 8. Calin GA, Croce CM. MicroRNA-cancer connection: 鈥榯he beginning of a new tale鈥? Cancer Res. 2006;66:7390鈥?. CrossRef 9. Volinia S, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257鈥?1. CrossRef 10. Bandr茅s E, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29. CrossRef 11. Chan SH, Wu CW, Li AF, Chi CW, Lin WC. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res. 2008;28:907鈥?1. 12. Zhang HH, Wang XJ, Li GX, Yang E, Yang NM. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol. 2007;13:2883鈥?. CrossRef 13. Ji Q, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 2008;8:266. CrossRef 14. Guo J, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009;24:652鈥?. CrossRef 15. Sobin LH, Wittekind CH, editors. TNM classification of malignant tumors 5th edition, International Union Against Cancer (UICC). New York: Wiley; 1997. p. 59鈥?2. 16. Solcia E, et al. Endocrine tumours of the gastrointestinal tract. In: Solcia E, Kl枚ppel G, Sobin LH, editors. Histological typing of endocrine tumours. 2nd ed. Berlin: Springer-Verlag; 2000. p. 61鈥?. 17. Lawrie CH, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672鈥?. CrossRef 18. Peng JJ, et al. Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers. World J Gastroenterol. 2007;13:3009鈥?5. 19. Wang SL, et al. Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis. Mol Cell Biochem. 2008;308:93鈥?00. CrossRef 20. Yan LX, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14:2348鈥?0. CrossRef 21. Shen J, et al. MicroRNAs regulate ocular neovascularization. Mol Ther. 2008;16:1208鈥?6. CrossRef 22. Guglielmelli P, et al. MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol. 2007;35:1708鈥?8. CrossRef 23. Wong QW, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology. 2008;135:257鈥?9. CrossRef 24. Wong TS, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14:2588鈥?2. CrossRef
1. Ningbo University School of Medicine, 315211, Ningbo, China 2. Affiliated Hospital (Ningbo No. 2 Hospital), Ningbo University School of Medicine, 315010, Ningbo, China
文摘
MicroRNAs (miRNAs) are non-coding RNAs that regulate the expression of target mRNAs. Altered expression of specific miRNAs in several tumor types has been reported. However, the expression levels of miR-31 in gastric cancers are unclear. The objective of the present study was to compare the expression profile of miR-31 between gastric cancer tissues and non-tumor tissues. Real-time quantitative reverse transcription-polymerase chain reaction technology was used to detect the levels of miR-31 expression. The expression levels of miR-31 in gastric cancer tissues were significantly lower than those in non-tumor tissues. This new information may help to clarify the molecular mechanisms involved in gastric carcinogenesis and to indicate that miR-31 may be a novel diagnostic biomarker of gastric cancer.